LobbyingAcadia Pharmaceuticals lobbying by quarter
Acadia Pharmaceuticals ACAD's latest lobbying report covers Q2 2026, at $800K. The four quarters Q4 2025–Q3 2026 total $2.2M. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Health Issues.
Acadia PharmaceuticalsACAD
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $2.2M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $460K | 3 |
| Q1 2023 | $480K | 3 |
| Q2 2023 | $320K | 3 |
| Q3 2023 | $270K | 3 |
| Q4 2023 | $330K | 3 |
| Q1 2024 | $340K | 3 |
| Q2 2024 | $540K | 3 |
| Q3 2024 | $310K | 3 |
| Q4 2024 | $610K | 4 |
| Q1 2025 | $550K | 4 |
| Q2 2025 | $620K | 5 |
| Q3 2025 | $890K | 5 |
| Q4 2025 | $730K | 5 |
| Q1 2026 | $700K | 3 |
| Q2 2026 | $800K | 3 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$3.1M · 30 reports
- Medicare and Medicaid$2.6M · 37 reports
- Taxation$1.6M · 18 reports
- Trade$375.8K · 3 reports
- Budget and appropriations$92.5K · 1 reports
- Defense$92.5K · 1 reports
- Medical research and clinical labs$65K · 13 reports
- Pharmacy$35K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES52 reports
- SENATE52 reports
- Executive Office of the President (EOP)3 reports
- Food & Drug Administration (FDA)3 reports
- Health & Human Services, Dept of (HHS)3 reports
- Treasury, Dept of3 reports
- Natl Economic Council (NEC)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAcadia Pharmaceuticals | $6.4M | 15 quarters |
| Tiber Creek Group | $1.2M | 15 quarters |
| Holland & Knight | $130K | 7 quarters |
| The Conafay Group | $130K | 13 quarters |
| LMH Strategic Solutions | $70K | 3 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ALANNA TEMME | Legislative Director, U.S. Representative Jon Porter | Q4 2025 |
| DARIN L GARDNER | Legislative Correspondent to Senator Tim Hutchinson; Research Assistant for Senate HELP Committee; Chief of Staff for Congresswoman Kay Granger | Q4 2025 |
| ANDREW JOSEPH SIRACUSE | Sr. Tax Cnsl., Sen. John Cornyn; Staff Dir., Sen. Fin. Cmte. Int'l. Trade, Customs & Global Comp. Sbcmte., Tax Cnsl., Sen. Cornyn; Cnsl. Sen. Cornyn; Staff Dir. Sen. Fin. Cmte, Energy, Nat. Res. Sbcmte.; LA, Sen. Cornyn; LA, Sen. Norm Coleman | Q3 2025 |
| JOHN KIRKLAND TWOMEY | Chief of Staff, HHS Office of the Asst. Sec. for Legislation (2019-2021); Policy Adviser, HHS (2017-2019); Special Asst., Office of the Secretary, HHS (2017); Staff Assistant, Rep. Tom Price (2015-2017); Intern, Rep. Doug Collins (2015) | Q4 2024 |
| BRYAN SHUY | Chief of Staff Rep. Harris; Asst. to Rep. Harris, House Cmte on Approps; Dep. Asst. Sec and Chief of Staff HHS/Asst. Secretary for Preparedness and Response (ASPR) | Q2 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $700K |
| 07/19for Q2 | Tiber Creek Group | $80K |
| 07/10for Q2 | Holland & Knight | $20K |
| 04/20for Q1 | In-house | $600K |
| 04/18for Q1 | Tiber Creek Group | $80K |
| 04/16for Q4 2025 | LMH Strategic Solutions | $30K |
| 04/10for Q1 | Holland & Knight | $20K |
| 01/20for Q4 2025 | The Conafay Group | $10K |
| 01/19for Q4 2025 | In-house | $590K |
| 01/17for Q4 2025 | Tiber Creek Group | $80K |
| 01/13for Q4 2025 | Holland & Knight | $20K |
| 01/12for Q4 2025 | LMH Strategic Solutions | $30K |
| 25/10/20for Q3 2025 | The Conafay Group | $10K |
| 25/10/20for Q3 2025 | LMH Strategic Solutions | $30K |
| 25/10/19for Q3 2025 | In-house | $750K |
| 25/10/19for Q3 2025 | Tiber Creek Group | $80K |
| 25/10/15for Q3 2025 | Holland & Knight | $20K |
| 25/07/21for Q2 2025 | LMH Strategic Solutions | $10K |
| 25/07/21for Q2 2025 | In-house | $500K |
| 25/07/20for Q2 2025 | Tiber Creek Group | $80K |